EP2827903 - POTENTIATING ANTIBODY-INDUCED COMPLEMENT-MEDIATED CYTOTOXICITY VIA PI3K INHIBITION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.01.2017 Database last updated on 08.10.2024 | Most recent event Tooltip | 06.01.2017 | Application deemed to be withdrawn | published on 08.02.2017 [2017/06] | Applicant(s) | For all designated states Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, NY 10065 / US | [2015/05] | Inventor(s) | 01 /
WU, Xiaohong 105-05 69th Avenue Apt 301 Forest Hills, NY 11375 / US | 02 /
SCHOLZ, Wolfgang, W. 7192 Sherbourne Lane San Diego, CA 92129 / US | 03 /
RAGUPATHI, Govind 303 E 60th St 35g New York, NY 10022 / US | 04 /
LIVINGSTON, Philip, O. 89 Myrtle View Street Bluffton, SC 29910 / US | [2015/05] | Representative(s) | Lee, Nicholas John, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
Former [2015/05] | Cornish, Kristina Victoria Joy, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 13764228.6 | 14.03.2013 | WO2013US31278 | Priority number, date | US201261614942P | 23.03.2012 Original published format: US 201261614942 P | [2015/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013142245 | Date: | 26.09.2013 | Language: | EN | [2013/39] | Type: | A1 Application with search report | No.: | EP2827903 | Date: | 28.01.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.09.2013 takes the place of the publication of the European patent application. | [2015/05] | Search report(s) | International search report - published on: | US | 26.09.2013 | (Supplementary) European search report - dispatched on: | EP | 12.01.2016 | Classification | IPC: | A61K39/395, A61K39/00, A61K39/385, A61K39/39, A61K31/4375, A61K31/4745, A61K31/5377, C07K16/28, C07K16/30, C12Q1/68, G01N33/574, A61P35/00 | [2015/43] | CPC: |
A61K39/39558 (EP,US);
A61K31/4375 (EP,US);
A61K31/4745 (EP,US);
A61K31/5377 (EP,US);
A61K39/0011 (EP,US);
A61K39/001124 (EP,US);
A61K39/00117 (EP,US);
A61K39/001171 (EP,US);
A61K39/001172 (EP,US);
A61K39/001173 (EP,US);
A61K39/001194 (EP,US);
A61K39/385 (US);
A61K39/39 (US);
A61P35/00 (EP);
C07K16/2887 (EP,US);
C07K16/3084 (EP,US);
C12Q1/6886 (US);
G01N33/57484 (US);
A61K2039/505 (EP,US);
A61K2039/507 (EP,US);
A61K2039/545 (EP,US);
C07K2317/73 (EP,US);
C07K2317/94 (EP,US);
C12Q2600/106 (US);
| C-Set: |
A61K39/0011, A61K2300/00 (EP,US);
A61K39/39558, A61K2300/00 (US,EP) |
Former IPC [2015/05] | A61K39/395, A61K39/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/05] | Title | German: | POTENZIERUNG EINER ANTIKÖRPERINDUZIERTEN KOMPLEMENTVERMITTELTEN ZYTOTOXIZITÄT MITTELS PI3K-HEMMUNG | [2015/05] | English: | POTENTIATING ANTIBODY-INDUCED COMPLEMENT-MEDIATED CYTOTOXICITY VIA PI3K INHIBITION | [2015/05] | French: | POTENTIALISATION DE LA CYTOTOXICITÉ À MÉDIATION PAR LE COMPLÉMENT INDUITE PAR UN ANTICORPS PAR L'INTERMÉDIAIRE D'UNE INHIBITION DE PI3K | [2015/05] | Entry into regional phase | 22.10.2014 | National basic fee paid | 22.10.2014 | Search fee paid | 22.10.2014 | Designation fee(s) paid | 22.10.2014 | Examination fee paid | Examination procedure | 22.10.2014 | Examination requested [2015/05] | 23.04.2015 | Amendment by applicant (claims and/or description) | 09.08.2016 | Application deemed to be withdrawn, date of legal effect [2017/06] | 14.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/06] | Fees paid | Renewal fee | 27.03.2015 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.03.2016 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2011153488 (ONCOTHYREON INC [US], et al); | International search | [Y]US2004151733 (LIVINGSTON PHILIP O [US], et al); | [X]US2009136516 (TEDDER THOMAS F [US], et al); | [X]US2010233164 (EBENS JR ALLEN J [US], et al); | [X]US2011178070 (GONG XIANCHANG [US], et al); |